News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hewitt L Arthur
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/25/2014 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Unknown transaction of 58,683 shares
@ $0
Disposed/sold 218,923 shares
@ $0
Exercised 68,923 options to buy
@ $2.62, valued at
$180.6k
Exercised 50,000 options to buy
@ $1.78, valued at
$89k
Exercised 50,000 options to buy
@ $1.24, valued at
$62k
Exercised 50,000 options to buy
@ $0.96, valued at
$48k
Disposed/sold 50,000 options to buy
@ $7.72, valued at
$386k
Disposed/sold 50,000 options to buy
@ $6.5, valued at
$325k
Disposed/sold 50,000 options to buy
@ $5.68, valued at
$284k
Disposed/sold 50,000 options to buy
@ $4.65, valued at
$232.5k
Disposed/sold 50,000 options to buy
@ $4.54, valued at
$227k
|
|
| 01/24/2014 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $4.65, valued at
$232.5k
|
|
| 01/09/2013 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $0.96, valued at
$48k
|
|
| 07/11/2012 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $1.24, valued at
$62k
|
|
| 01/27/2012 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $4.54, valued at
$227k
|
|
| 01/13/2011 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $7.72, valued at
$386k
|
|
| 01/21/2010 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $2.96, valued at
$148k
|
|
| 02/02/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/26/2009 |
4
| Hewitt L Arthur (Vice Pres. of Drug Development) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
|
|